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Summary
Objective: To investigate the gene expression of estrogen receptor (ER)  and ER in human articular chondrocytes.
Methods: 16 articular cartilage specimens were obtained from 15 patients during surgery. Three of the specimens were from men and 13
from women; three from hip joints and 13 from knee joints; four were normal and 12 showed osteoarthritic cartilage. Total RNA was extracted
from the articular chondrocytes and the expression of both ER and ER genes was investigated by the reverse transcription-polymerase
chain reaction (RT-PCR) method.
Results: Gene expressions of ER were detected in all specimens and those of ER were found in 15 specimens by the RT-PCR method.
There was a significant correlation between the amounts of ER and ER. Expression levels of both genes were significantly higher in men
than in women. There were no significant differences in the expression levels of both ER genes between the hip and knee joint sites, nor
between normal and osteoarthritic tissues.
Conclusion: This study is to our knowledge the first to demonstrate the gene expression of both ER and ER in human articular
chondrocytes. Since there are some functional differences between the two receptors, the effects of estrogen on cartilage metabolism should
be elucidated by two different receptor mechanisms. © 1999 OsteoArthritis Research Society International
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There are significant sex differences regarding the preva-
lence and clinical manifestations of osteoarthritis (OA). OA
is more likely to occur in women, especially postmenopau-
sal, and the symptoms are more severe than in
men. Therefore, the potential role of estrogens in the
pathogenesis of OA has been suggested.1–7
As a possible mechanism of estrogen action, it has been
suggested that estrogen affects articular cartilage metab-
olism directly via an estrogen receptor (ER) in chondro-
cytes. An ER in chondrocytes has been detected by
radioligand assay,8–14 immunoprecipitation,10,14–17 auto-
radiography,13,15,18 and in-situ hybridization.16 Some
studies, however, have failed to show the presence of an
ER in chondrocytes by radioligand assay.19,20 Most of the
previous studies were carried out using cultured chondro-
cytes from animal or human epiphyseal cartilages, whereas
the presence of an ER in human articular cartilage has
been confirmed only in one report, by Tsai et al.11
Recently, it has become evident that there is not only a
classical ER (ER), but also a novel ER (ER).21,22 The
tissue distribution of the two receptors was found to be
different in rat and human fetuses.23,24 In the human fetus,560ER mRNA is most abundant in the uterus, while high
amounts of ER mRNA are present in the ovaries, testes,
adrenals, and spleen.24 The levels of transactivation are
higher for ER than for ER, although estradiol binds to
both ER and ER and their binding affinity is almost
identical.22,23 These observations suggest different organ-
specific roles for the two receptors. Nillson et al.17 demon-
strated of ER immunoreactivity in human growth plate
cartilage. Until now, it is not known what type of ER is
expressed in human articular chondrocytes.
In this study, we investigated the expression of ER and
ER genes in human articular chondrocytes in relation to
joint sites, sex, and osteoarthritic changes.Materials and methodsReceived 9 March 1999; accepted 15 June 1999.
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Articular cartilage tissues from 16 joint sites of 15
patients (12 women and three men) aged from 39 to 85
(mean 70.5), were obtained during orthopedic surgery. Of
the 16 specimens, three were from men and 13 from
women. Three were from hip joints and 13 from knee joints.
Of the 13 knee specimens, 12 were obtained during total
knee replacement for knee OA, and one during above knee
amputation for a malignant bone tumor of the distal femur,
the former being categorized as osteoarthritic and the latter
as normal. Three hips underwent endoprosthetic replace-
ment for a femoral neck fracture, being categorized as
having normal cartilage. As a result, four specimens were
normal and 12 were osteoarthritic cartilage. Patient details
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of the femoral condyle and tibial plateau (knee), or
of the femoral head (hip), was carefully sliced off, not
including the calcified cartilage layer or subchondral
bone, and immediately preserved in liquid nitrogen. All
women were postmenopausal and had never received
hormonal replacement therapy. None of them received an
intra-articular injection within one month before surgery.RNA EXTRACTION
Total RNA was isolated by the acid guanidinium
isothiocyanate-phenol-chloroform method25 with slight
modification. Briefly, the sliced cartilage specimen, pre-
served in liquid nitrogen, was homogenized in 10 volumes
of 4 M guanidinium isothiocyanate/50 mM Tris-HCl
(pH 7.5)/10 mM EDTA/2% sodium dodecyl sarcosinate/
150 mm 2-mercaptoethanol using a homogenizer (HG-30,
HITACHI, Tokyo, Japan). Two volumes of 0.1 M sodium
acetate buffer (pH 5.2)-saturated phenol/chloroform were
then added and the mixture was vigorously shaken at
60°C. The aqueous phase was recovered, then an equal
volume of 0.1 M sodium acetate buffer-saturated phenol/
chloroform was added to it, and the mixture was shaken at
room temperature until the aqueous phase became clear.
The aqueous phase was recovered, an equal volume of
chloroform was added, and the mixture was shaken again.Then two volumes of absolute ethanol were added to the
recovered aqueous phase and the mixture was allowed to
stand for 18 h at −20°C. After centrifugation (10,000 g,
20 min at 4°C), the pellet was dissolved in 1 ml of 0.1 M
Tris-HCl (pH 7.5)/50 mM NaCl/10 mM EDTA/0.2% SDS
containing proteinase K (100 g/ml) and incubated for 1 h
at 37°C. The solution was treated with saturated phenol/
chloroform, following ethanol precipitation. After centrifuga-
tion (15,000 g, 20 min at 4°C), the pellet was dissolved in
3 mM sodium acetate buffer (pH 5.2).
To remove genomic DNA contamination, each sample
was treated with DNase I (RNase-free, Nippongene,
Toyama, Japan) in the presence of RNase inhibitor (Wako
pure chemical, Osaka, Japan) for 1 h at 37°C, followed by
proteinase K digestion, phenol/chloroform extraction, and
ethanol precipitation. The pellet was dissolved in 3 mM
sodium acetate buffer (pH 5.2) again and quantified
spectrophotometrically at 260 nm.Table I
Clinical information for each patient
Patient
No.
Age
(y)
Sex Joint
site
Disease Cartilage
status
Cartilage
specimen
1 70 f Knee OA OA Fem and tib
2 75 f Knee OA OA Fem and tib
3 67 f Knee OA OA Fem and tib
4 77 f Knee OA OA Fem and tib
5 77 f Knee OA OA Fem and tib
6R 63 f Knee OA OA Fem and tib
6L 63 f Knee OA OA Fem and tib
7 71 f Knee OA OA Fem and tib
8 73 f Knee OA OA Fem and tib
9 72 f Knee OA OA Fem and tib
10 80 m Knee OA OA Fem and tib
11 64 m Knee OA OA Fem and tib
12 84 f Hip Femoral neck fracture Normal Femoral head
13 85 f Hip Femoral neck fracture Normal Femoral head
14 61 f Hip Femoral neck fracture Normal Femoral head
15 39 m Knee Bone tumor Normal Fem and tib
OA, osteoarthritis; fem, femoral condyle; tib, tibial plateau.Table II
Sequences of primers
Gene Sequence Size
(bp)
Reference
ER Sense 5′-GACCGAAGAGGAGGGAGAA-3′ 460 26
Anti-sense 5′-CCAAGAGCAAGTTAGGAGCAA-3′
ER Sense 5′-TAGTGGTCCATCGCCAGTTAT-3′ 323 27
Anti-sense 5′-GGGAGCCACACTTCACCAT-3′
Sense nested 5′-CGGAACCTCAAAAGAGTCCCTGG-3′
Anti-sense nested 5′-CCGAAGTCGGCAGGCCTGGCAGC-3′
GAPDH Sence 5′-GAGTCAACGGATTTGGTCGT-3′ 156 28
Anti-sense 5′-GGTGCCATGGAATTTGCCAT-3′RT-PCR (REVERSE TRANSCRIPTION-POLYMERASE CHAIN
REACTION)
RT-PCR was performed using an RNA PCR kit (TAKARA
SHUZO, Otsu, Japan). Briefly, reverse transcription of RNA
into cDNA was performed by incubating 2 g of total RNA
with AMV reverse transcriptase, 9 mer random primers,
dNTP, and RNase inhibitor at 30°C for 10 min, followed by
562 T. Ushiyama et al.: Estrogen receptors in articular chondrocytesFig. 1. RT-PCR amplification of ER and ER mRNA in human articular chondrocytes. The photograph of polyacrylamide gel electrophoresis
shows the gene expression of ER, ER, and GAPDH as single bands of expected sizes in each cartilage specimen.Fig. 2. Direct sequencing of ER and ER PCR amplified products.
The nucleotide sequences of the amplified cDNA fragments for
both ER and ER were consistent with those of ER and ER,
respectively.42°C for 30 min. One microliter (50 ng) of each cDNA
sample from the above extractions was amplified by PCR in
a total volume of 100 l using 2.5 units of Ex Taq polym-
erase with the accompanying buffer, 200 m dNTP mixture
(TAKARA SHUZO), and 0.2 m each of specific oligonucle-
otide primers. The oligonucleotide primers were prepared
according to the published sequence of the human gene for
ER,26 and previous reports for ER27 and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH)28 (Table II). PCR
was performed using a GeneAmp System 2400 (Perkin
Elmer). The PCR condition for ER was 35 cycles (94°C for
30 sec, 65°C for 30 sec, 72°C for 1 min). For ER, nested
PCR was performed. After 20 cycles (94°C for 30 sec, 53°C
for 30 sec, 72°C for 1 min), 5 l of the first PCR product
was amplified again with nested primers in the same PCR
condition for 20 cycles. The PCR condition for GAPDH was
20 cycles (94°C for 30 sec, 55°C for 30 sec, 72°C for
30 sec). As a negative control, the above PCR procedure
was performed simultaneously with an RNA sample that
had not been reverse-transcribed and with distilled water,
instead of cDNA. The amplified products were separated
by electrophoresis using 6% polyacrylamide gels. To deter-
mine the size of the fragments, a 100 bp DNA ladder (Gibco
BRL, MD, U.S.A.) was used as the marker. The gels were
stained using ethidium bromide (0.5 g/ml) and the cDNA
bands were photographed under UV illumination. The flu-
orescent intensity of the expected bands was semi-
quantified by computer analysis, i.e., the photographs
were scanned and analysed using Adobe Photoshopsoftware (Adobe Systems Inc., CA, U.S.A.). Results
were normalized for GAPDH mRNA and expressed in
arbitrary units.
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The ER and ER cDNA fragments, extracted from 6%
polyacrylamide gels, were sequenced using an ABI 310
sequencer (Perkin Elmer, CA, U.S.A.) according to the
manufacturer’s protocol.STATISTICAL ANALYSIS
We used a Student’s t-test to compare the levels of
gene expression between two groups, as well as linear
regression analyses.Fig. 3. Relative levels of ER and ER gene expression in human articular cartilage. The calculated amounts of PCR products of ER (h)
and ER (") standardized by that of GAPDH are shown for 16 cartilage specimens.Results
In each PCR procedure, the amount of PCR product
increased for up to 40 cycles for ER and GAPDH, and for
up to 20 cycles in nested PCR for ER, and increased
almost linearly as a function of the amount of total RNA
used (data not shown). No PCR product was observed in
the procedures with the RNA sample that had not been
reverse-transcribed or with distilled water, instead of cDNA,
showing that the amplified product was mRNA-specific and
that there was no genomic DNA contamination.Figure 1 is a photograph of the polyacrylamide gel
electrophoresis showing the expression of ER, ER, and
GAPDH as single bands of expected sizes for each carti-
lage specimen. Expression of the ER gene was detected
in all 16 specimens and that of the ER gene was detected
in 15 by this method. The nucleotide sequences of these
amplified ER and ER cDNA fragments were consistent
with those of ER and ER, respectively26,27 (Fig. 2).
The amount of the PCR products for each specimen
standardized by that of GAPDH are shown in Fig. 3. Figure
4 shows the correlation of the amount of gene expression
between ER and ER in each specimen. The expression
of both ER genes was correlated with each other using
linear regression (ER=0.197+0.938 ER, r2=0.641,
P=0.0002).
The amounts of gene expression were compared
between various categories: men and women, joint sites,
and normal and osteoarthritic cartilage. Gene expression
levels were significantly higher in men than in women for
ER (P=0.015) and ER (P=0.001) (Fig. 5). There were no
significant differences for either ER type between hip and
knee, or between normal and osteoarthritic cartilage.
The correlation between the amount of each ER and age
was analysed using a linear regression model. Although
there was no significant relationship between the patients’
564 T. Ushiyama et al.: Estrogen receptors in articular chondrocytesage and ER gene expression (P=0.43), there was a mild
tendency between the patients’ age and ER gene expres-
sion (P=0.09). In a separate analysis, the correlation
between ER gene expression levels and age was analysed
by sex, yielding again no significant relationship (data not
shown).Fig. 4. Correlation of gene expression levels between ER and
ER. The expression of both ERs were correlated with each other
(ER=0.197+0.938 ER, r2=0.641, P=0.0002).Fig. 5. Comparison of gene expression levels of both ERs between men (N=3) and women (N=13). For both ER and ER, men had a
higher expression level in amounts.Discussion
In this study we demonstrated the expression of both
ER and ER genes in human articular cartilage by the
RT-PCR method. We detected ER mRNA in a fresh frozen
cartilage specimen, indicating in-vivo ER expression in
human articular chondrocytes. The levels of ER and ER
gene expression were correlated with each other. Men
showed a significantly higher level of gene expression for
both types of ERs than women. There were no apparentdifferences between joint sites, or between normal and
osteoarthritic cartilage.
There has been an accumulating knowledge that estro-
gen modulates the metabolism of chondrocytes. Admin-
istration of estradiol worsened the erosive changes in
meniscectomy-induced OA in rabbits, and this effect of
estrogen was inhibited by tamoxifen, an estrogen
antagonist.29–31 Knee OA is induced by an intra-articular
injection of estradiol in rabbits.32 Cyclofenil diphenol, a
non-steroidal weak estrogen, inhibited the synthesis of
proteoglycan and hyaluronate in primary cultures of
chondrocytes from the Swarm rat chondrosarcoma.33 Tes-
tosterone and estradiol synergized with IL-1 in the induction
of IL-6 in human articular chondrocytes.34 These results
suggest that an overdose of estradiol has an adverse effect
on the articular cartilage.
On the other hand, in a study by Corvol et al.,35 estradiol
had stimulatory effects on cartilage proteoglycan synthesis
in cultured chondrocytes from rabbits, and the response of
female-derived cells was twice that of male-derived cells.
Estradiol as well as testosterone stimulated DNA synthesis
of chondrocytes from rat epiphyseal cartilage.36 Itagane
et al.37 noted that sex hormones such as estrogen, proges-
terone, and testosterone had no stimulatory effects on DNA
synthesis in rabbit chondrocytes, but they have priming
effects on the biological action of insulin-like growth factor-I
which affects the metabolism of the cartilage. In a recent
study by Morisset et al.,38 estradiol inhibited COX
(cyclooxygenase)-2 in basal conditions in primary
cultures of bovine chondrocytes. The protective effects of
estrogen on the mechanical property of articular cartilage in
ovariectomized sheep were shown by Turner et al.39
These conflicting results regarding the effects of estro-
gen on articular cartilage may be due to the differences
between human and animal species, epiphyseal and articu-
lar cartilage, and in vivo and in vitro studies. Assuming that
ER and ER are functionally different, the status of
differential expression of two different ERs could partly
explain the controversy surrounding the role of estrogen in
Osteoarthritis and Cartilage Vol. 7 No. 6 565cartilage metabolism. Interestingly, ER and ER are
expressed differently during human osteoblast differentia-
tion.27 ER mRNA expression increased gradually during
osteoblast culture, whereas ER mRNA expression levels
increased slightly at the beginning and soon remained
constant, suggesting an additional functional role of ER to
ER in bone metabolism. Therefore, the functional role of
the two ERs in chondrocyte metabolism should be
addressed in future studies.
From a clinical point of view, it is easier to postulate that
estrogens are beneficial to articular chondrocyte metab-
olism, because the age at onset of OA in women has been
found to coincide with the perimenopausal period when
serum estrogen levels rapidly decline.1 In fact, some
studies have shown that estrogen replacement therapy has
protective effects for hip and knee OA.40,41 The one para-
doxical fact against the beneficial role of estrogen on
cartilage is a high female to male prevalence ratio shown
by epidemiological surveys of OA.1 Estrogen levels are
generally higher in women than in men, although sex
steroid levels in both genders tend to converge in older
age.42 As shown in the present study, women have a lower
level of ER and ER, suggesting that women would be
more prone to a fluctuation in serum estrogen levels. This
might give a possible explanation for the apparent paradox.
In this study, however, the number of cartilage speci-
mens were small, especially in the male and control sub-
jects, and the histological findings presenting the
degenerative status of cartilage were not evaluated. There-
fore, the expression of both ERs in various joint sites in
relation to age, sex, and cartilage status, and the events
that follow estrogen binding to both ERs in articular
chondrocytes need to be elucidated in further studies.Acknowledgments
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